Under the name TopFit Impact Programme, Radboudumc, Radboud University, the University of Twente and Wageningen University & Research, join together in an impact programme aimed at preventing and reducing disease and the burden of disease.
FrameworkMuch progress has been made in recent years in understanding disease processes and the development of new treatment methods. At the same time, the realization that many diseases will remain incurable for the foreseeable future grows. Through smart integration of innovative technologies and knowledge about nutrition and health we can be one step ahead of disease and its burdens.
These integral solutions mean that there will be an ever more personal approach in healthcare. The payoff is a maximum increase in the quality of life of patients and the best perspective on affordable healthcare in an aging society. The goal of the TopFit programme is to contribute to controlling and limiting the cost of healthcare in the future, without making concessions to the quality of life of patients.
ImpactTopFit aspires to be a leading health impact programme on three levels: society & health, innovation & (regional) economy and science & technology. Therefore, the researchers work together with key partners in the east of the Netherlands.
During the summer of 2018 the programme will be further specified. After that, more information about TopFit will be available.
ContactAre you interested in the TopFit Impact Programme? Do you want to be involved or do you have questions? Please contact Nathalie Bovy-vanderLugt.
Related news items
HFSP Grant for Johannes Textor30 March 2020
Johannes Textor, theme Cancer development and immune defense, has been awarded a program grant of 1 million US dollars by The Human Frontier Science Program (HFSP) to investigate how T cells navigate extremely dense environments using experiments, modeling and methods from pedestrian dynamics.read more
Ritalin enhances your ability to do tasks by making you more motivated26 March 2020
A new study uncovers how stimulants like Ritalin work in the brain, and it challenges some misconceptions for its recreative use. The collaboration between Radboudumc and Brown University (USA) was published in the journal Science.read more
Dealing with COVID-19 in low- and middle-income countries26 March 2020
RIHS researcher Joost Hopman believes that low-and middle-income countries should intensify their preparedness for a possible COVID-19 outbreak. This was the core message of an opinion article that he wrote at the request of the medical journal JAMA.read more
Physiotherapy is important to the recovery of patients with the coronavirus26 March 2020
Patients who have been infected with the coronavirus and admitted to the hospital for this reason should receive physiotherapy as soon as their condition allows. This is the view expressed by physiotherapists and researchers from the Radboudumc in a set of joint treatment recommendations.read more
Healthcare utilization and regional variation of end-of-life hospital care in Dutch cancer patients26 March 2020
In International Journal of Quality Health Care RIHS researcher Femke Atsma showed high healthcare utilization and medical variation in End of Life care in Cancer patients, which was not associated with GP care or long term care.read more